Navigation Links
WHOI researchers, collaborators receive $1.4 million grant to study life in ocean's greatest depths
Date:3/27/2012

ok nearly a decade to design and build. On its maiden voyage in 2009, Nereus successfully dove to the Challenger Deep, an area nearly 36,000 feet below the surface, providing new and unprecedented access to the deepest parts of the ocean floor.

"With a robot like Nereus, we can now explore virtually anywhere in the ocean," said Andy Bowen, the project manager and principal developer of the vehicle. "It marks the start of a new era in ocean exploration and research."

The unmanned vehicle can operate either as an autonomous, free-swimming robot for wide-area surveys, or as a tethered vehicle for close-up investigation and sampling. It will allow researchers to gather high definition video along the trench axis, as well as recover organisms and sediment samples.

The HADES program will begin its work in 2013 at the Kermadec Trench, an area roughly 750 miles long and 32,963 feet (10,047 meters) deep located off the northeastern tip of New Zealand. It will later conduct expeditions to the Mariana Trench near the island of Guam in the west Pacific.

This expedition will build on studies of the Kermadec Trench by HADES program collaborator Alan Jamieson at UA's Oceanlab and colleagues at NIWA and the University of Tokyo. Using a state of the art, free-falling autonomous baited camera system, the research team documented many new species of animals in the Kermadec and other trenches around the Pacific Rim in the past few years.

"To date, this method has been successful in observing the deepest fish ever seen alive," Jamieson said. "By combining WHOI's HROV Nereus with Oceanlab's Hadal-Lander technology, the team have the best available technology at their disposal."

Despite the harsh conditions in ocean trenchesicy temperatures, intense pressure, no sunlightsome species are able to thrive there. For one reason, food is plentiful, as organic material in the ocean is moved by currents and pulled down into the abyss.

"We know there's an excess foo
'/>"/>

Contact: Media Office
media@whoi.edu
508-289-3340
Woods Hole Oceanographic Institution
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Louisiana Tech University researchers, NASA partner to conduct zero-gravity experiments
2. Vanderbilt researchers, international team, uncover genes linked to multiple sclerosis
3. USDA researchers, collaborators sequence genomes of fungi that threaten wheat, poplars
4. Scripps researchers, UCSD chemists to create center devoted to chemistrys influence on climate
5. BGI and Collaborators Announce New Clues Found in Tracing the Origin of the Deadly E. coli Strain and Appeal for the Sharing of Additional Data
6. Novartis and collaborators discover novel antimalarial drug candidate
7. K-State researcher, collaborators study virulence of pandemic H1N1 virus
8. Clemson and collaborators receive $1.1 million to improve durability of concrete infrastructure
9. In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics
10. Florida State chemist to receive prestigious award for rising faculty stars
11. Monell scientist receives AchemS Ajinomoto Award for Young Investigators in Gustation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2014)... increased resistance to bacterial pneumonia in female mice to ... , Females are naturally more resistant to respiratory infections ... shown that increased resistance to bacterial pneumonia in female ... 3 (NOS3). They also show that this enzyme is ... hormone estrogen. , The team, lead by Professor Lester ...
(Date:10/15/2014)... Alt will be awarded the 44th Rosenstiel Award for ... his pioneering research exploring the mechanisms of genomic instability ... cells. Alt is the second alumnus to win the ... Prize in 2003. , Alt is the Charles A. ... Harvard Medical School and an investigator at the Howard ...
(Date:10/14/2014)... N.C. – Like discriminating thieves, prostate cancer tumors scavenge ... the body. But such avarice may be a fatal ... a way to kill prostate cancer cells by delivering ... selectively destroys the diseased cells brimming with the mineral, ... uses two drugs already commercially available for other uses, ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Prostate cancer's penchant for copper may be a fatal flaw 2
... Rainmakers, Inc., an intellectual property holding company and advanced ... its "stealth" mode and is prepared to actively commercialize ... security offerings. , During the past four years, the ... develop and deploy a series of core--but expandable--technologies built ...
... up 45 percent of blood, normally take the shape of ... can sometimes deform into an asymmetrical slipper shape. A ... flow might be responsible for this deformation, as well as ... could help understand the mechanisms involved in arterial disease and ...
... CAMDEN Contrary to a national trend, more and ... major in math and science. Thanks to a $307,277 ... students in the sciences at RutgersCamden will receive unprecedented ... of their degrees. Through a new RutgersCamden program ...
Cached Biology News:Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3NSF grant supports Rutgers-Camden program for science majors 2NSF grant supports Rutgers-Camden program for science majors 3
(Date:10/20/2014)... BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced four ... million and provides a good start to Q4.  The orders are ... and one in the Middle East . ... said Peter Bruijns , President & CEO. "Total bidding activity ... they have been for any complete year since the company has ...
(Date:10/20/2014)... N.J. (PRWEB) October 20, 2014 ... the Sidney Kimmel Cancer Center at Thomas Jefferson ... , Through the Strategic Alliance Partnership program, ... OncLive will collaborate to raise awareness of the ... treatment, and other projects. Clinicians and other health ...
(Date:10/19/2014)... October 20, 2014 OCTOBER ... Meeting (ABIM). ABIM will take place ... information about ABIM 2014 is now available ... Delegates representing companies and organizations from all ... obtain information on the latest products and ...
(Date:10/19/2014)... The Asia-Pacific Speech Analytics market report ... with analysis and forecast of revenue. This market is ... $208 million by 2019, at a Compound Annual Growth ... Browse through the TOC of the Asia-Pacific Speech Analytics ... analysis provided. It also provides a glimpse of the ...
Breaking Biology Technology:Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 2The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 4
... PARIS and LAUSANNE, Switzerland, September 7 ... Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical,group of ... prescription drugs that,target unmet medical needs, announced today ... granted an exclusive worldwide license to develop,and commercialise ...
... manufacture hydroxyapatite (HA) could be used to make stronger, ... University of Birmingham this week (7-10 September) presented work ... University, Edinburgh. Using Serratia bacteria, the ... surfaces such as titanium alloy, polypropylene, porous glass and ...
... Sept. 6 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq:, ... biotechnology company,focused on researching, developing, manufacturing and marketing,biopharmaceutical ... of,shareholders of 3SBio Inc. will be held on ... No.3 A1, Road 10, Shenyang Economy & Technology ...
Cached Biology Technology:Ipsen and Debiopharm Conclude an Exclusive Worldwide License Agreement for the Development and Commercialisation ff the Ipsen's Proprietary CDC25[1] Inhibitor (IRC-083864 or Debio 0931), an Anti-Cancer Agent 2Ipsen and Debiopharm Conclude an Exclusive Worldwide License Agreement for the Development and Commercialisation ff the Ipsen's Proprietary CDC25[1] Inhibitor (IRC-083864 or Debio 0931), an Anti-Cancer Agent 3Ipsen and Debiopharm Conclude an Exclusive Worldwide License Agreement for the Development and Commercialisation ff the Ipsen's Proprietary CDC25[1] Inhibitor (IRC-083864 or Debio 0931), an Anti-Cancer Agent 4Ipsen and Debiopharm Conclude an Exclusive Worldwide License Agreement for the Development and Commercialisation ff the Ipsen's Proprietary CDC25[1] Inhibitor (IRC-083864 or Debio 0931), an Anti-Cancer Agent 53SBio Inc. to Hold 2009 Annual General Meeting on October 12, 2009 2
Hucal Agx Antigen Expression Service Specificity: Hucal Agx ...
MHC. Sections include: the isolation and functional properties of antigen-presenting cells analysis of MHC class II endocytosis and peptide turnover analysis of signalling via MHC class II molecu...
... PAGE Cleavable ICAT Reagent ... Protein ID and Quantitation ... Electrophoresis (PAGE), isotope-coded affinity ... technology to facilitate the ...
Supplemental reagent for annexin V assay....
Biology Products: